chrisvoncsefalvay/vaers-outcomes huggingface dataset:
after fist shot had racing heart for about 2 days and increased anxiety.  a little headache. After the 2nd shot  i had a headache and was a little tired. I continued to develop sinus and eye problems in the next few weeks with sinus and eye pressure. I was treated with an antibiotic for a sinus infection.  3 months after my 2 nd shot I developed severe and debilitating vertigo with neck pain and vomiting and a headache. It took about 6 months for the vertigo to go away.  I started having more neck and shoulder pain along with some chest pain over the year but thought it was from exercise. I was just diagnosed with pleurisy with effusion and pericarditis.  I very strongly feel the connection with the vaccine and my recent diagnoses.  I am sensitive to most medicines and this one is just another.  I have also developed lung nodules that were not there until I got the vaccine.
rash and pain inj site. for 1 week Narrative:  Other Relevant History:
post-menopausal menstrual bleeding; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A 56-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Sep2022 at 13:15 as dose number unknown (booster), single (Lot number: GH9694) at the age of 56 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series completed, manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 3, manufacturer unknown), for COVID-19 immunization. The following information was reported: POSTMENOPAUSAL HAEMORRHAGE (medically significant) with onset 26Oct2022, outcome "recovering", described as "post-menopausal menstrual bleeding". Therapeutic measures were not taken as a result of postmenopausal haemorrhage.  Clinical course: It was reported that patient received More than 3 doses. Facility type vaccine Pharmacy or Drug Store. Patient did not receive any other vaccine in four weeks. Patient did not have covid prior vaccination and did not test positive covid post vaccination .  No follow-up attempts are possible. No further information is expected.
extra dose administered; no adverse events; This spontaneous report was received from a Nurse Practitioner and refers to a 18 year old female patient.  The patient's concurrent conditions, concomitant medications, past medical history and drug reactions/allergies were not provided.   On 08-JUL-2020, the patient was vaccinated with a fourth dose (extra dose administered) of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # S004578 and expiration date reported as 29-SEP-2021, given in the in the right deltoid (previous vaccination schedule and route of administration was not mentioned) for prophylaxis. At the reporting time no adverse events or symptoms were reported.  There was no product quality complaint involved.  The reporter considered extra dose administered as medically significant event. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp; devicelotnumber: S004578; expirationdate: 29-SEP-2021; deviceage and unit: 0 ; operatorofdevice: Health Care Professional; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
I went to the eye doctor on 07/01/2021 and was diagnosed with macular denegeneration.
DIZZINESS; BODY ACHE; MUSCLE STIFFNESS; JOINT PAIN; CHILLS; HEADACHE; FEVER; VACCINE EXPOSURE DURING PREGNANCY; SORE INJECTION SITE; FATIGUE; This spontaneous pregnancy report received from a patient concerned a 30 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: UNKNOWN) dose was not reported, administered on 04-APR-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On 04-APR-2021, the subject experienced sore injection site. On 04-APR-2021, the subject experienced fatigue. On 04-APR-2021, the subject experienced vaccine exposure during pregnancy. The date of the subject's last menstrual period and expected delivery date were not reported. On 05-APR-2021, the subject experienced body ache. On 05-APR-2021, the subject experienced muscle stiffness. On 05-APR-2021, the subject experienced joint pain. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced headache. On 05-APR-2021, the subject experienced fever. On 06-APR-2021, the subject experienced dizziness. Treatment medications (dates unspecified) included: paracetamol. The pregnancy was continuing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills on 06-APR-2021, was recovering from sore injection site, headache, body ache, joint pain, and muscle stiffness, had not recovered from fatigue, and dizziness, and the outcome of vaccine exposure during pregnancy and fever was not reported. This report was non-serious.
Heartbeat was faster and harder than usual. Heartbeat was irregular. Sore arms. Nose bled.
A 3 1/2 year old white female presented with a 2 day history of cough and fever. Her parents had similarly been ill with the father having a cough for the past 10 weeks, severe enough to produce paroxysms with retching and hypoxia. He was receiving home oxygen therapy and aerosolized bronchodilator medication. The child's exam was remarkable for erythematous tonsils and palpable cervical adenopathy. She was dx'd with a viral illness and placed on combination cough and cold medication. The child returned in 2 weeks, with worsening coughing and choking on mucus. Her exam was remarkable for stridor over her airway with erythematous throat palate. She was current on her immunizations, having received 4 DPT vaccinations. The child was started on aerosolized albuterol every 4 hours as needed, azithromycin 12/mg/kg/day for 5 days and Pediapred 1.0mg/kg/day for 5 days. The father was subsequently screened for pertussis by his physician and found to have a (+) IgM antibody titer. The child continued to have paroxysms of coughing over the next 6 weeks that gradually diminished. Most recent exam shows her to be healthy and thriving with no sequelae. Case linked with U2002-00570.
PT experienced itching/swelling at injection site. After 1 hour itching subsided/redness decreased.
Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: Patient came in several days after receiving her shingrix vaccine reporting redness and swelling in a small area around injection site. Patient has had no systemic issues or any other problems. Assumed to have had a light allergic reaction to shingrix. Recommended patient not to receive 2nd dose unless otherwise advised by family doctor, or patient is aware she may have a similar or more severe reaction the next time.
pain is very severe, includes all over the scrotum; includes all over the scrotum, with redness , induration , and kissing of the first layer of the skin; includes all over the scrotum, with redness , induration , and kissing of the first layer of the skin; kissing of the first layer of the skin all over the scrotum; inflammation of the scrotum; Got worse every day; This is a spontaneous report from a contactable physician. A 66-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL1284), via an unspecified route of administration on the Right arm on 07Jan2021 at a [SINGLE DOSE] for COVID-19 immunisation. Medical history included hyperlipidaemia from an unknown date and unknown if ongoing. There were no concomitant medications. The patient had the first dose on 19Dec2020. On 17Jan2021, the patient noticed inflammation of the scrotum which got worse every day. On 20Jan2021, the pain was very severe which included all over the scrotum, with redness and induration and kissing of the first layer of the skin. Therapeutic measures (Eli on ointment, triple antibiotic ointment Kenalog) were taken as a result of the events. The outcome of the events was not recovered.
Nocturnal leg pain (no particular area) within a week of the first dose.  Generally cleared up during the day but continued for one month.  After 2nd dose (April 1, 2021) had fever and body ache next day and only for one day.   In May,  began to have morning stiffness, and pain and weakness in hip joints and legs during the day especially after sitting  or longer periods.  Saw Dr. April 27th but didn't connect the symptoms to the vaccine.  Have been healthy and active and was surprised by sudden onset of symptoms.  Dr.  had no explanation.   Blood tests showed nothing unusual.  Started taking Tylenol, which relieved symptoms somewhat and continued yoga, swimming, and walking, all of which helped.  Still feel occasional pain and stiffness after inactivity, but weakness was greatly reduced.   Subsequently, developed pain and reduced range of motion in the shoulders and pain in the upper arm muscles, especially the left arm and shoulder.  Stretching and swimming improve the symptoms temporarily, but the pain returns, although not as severely as initially.   Some weakness also remains.
Information has been received from a health professional concerning a 74 year old female patient who on Sep 21 2004 was vaccinated IM with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 647724/0946N). Subsequently in approximately Sept 2004, the patient developed redness, soreness and pain at injection site. Unspecified medical attention was sought.
5/19/2021--chest tightness,  hard to breath, extreme right shoulder pain, low grade fever.  Went to  ER, kept overnight.  Put on Eliquis 5 mg twice daily.  Discharged to home.
psoriatic arthritis diminished, stiffness in joints diminished, redness and skin scales on elbows, hands, knees, and chin improving, symptom improvement following Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (psoriatic arthritis diminished, stiffness in joints diminished, redness and skin scales on elbows, hands, knees, and chin improving, symptom improvement following Moderna vaccine) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 019B21A) for COVID-19 vaccination.     The patient's past medical history included Lyme disease (Diagnosed at age 30.) since 1994 and Spinal cord injury. Concurrent medical conditions included Psoriatic arthritis (Chronic psoriatic arthritis) and Fibromyalgia. Concomitant products included METHOTREXATE and ETANERCEPT (ENBREL) for Arthritis, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for Attention deficit disorder, BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (SUBOXONE) for Opioid use disorder.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Apr-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (psoriatic arthritis diminished, stiffness in joints diminished, redness and skin scales on elbows, hands, knees, and chin improving, symptom improvement following Moderna vaccine). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (psoriatic arthritis diminished, stiffness in joints diminished, redness and skin scales on elbows, hands, knees, and chin improving, symptom improvement following Moderna vaccine) outcome was unknown.            Patient received the first dose of Moderna covid-19 vaccine on 01-Apr-2021 and reported that he suffered from chronic psoriatic arthritis over his entire body and after receiving the vaccine he reported that " Not one joint hurts" and he is please with the result he experienced today. All other symptoms are improving or has been diminished. Patient received the second dose on 29-Apr-2021.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Severe Pain with slight redness at injection site. Redness is about a 4x4" area to the left of injection site toward axilla. Patient advised to use ice and take Benadryl 25 mg every 6 hours and call if worse.
This spontaneous case reported by an other healthcare professional, describes the occurrence of administered expired product (vaccine expired) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 037A21B) for COVID-19 immunization. No medical history reported. Concomitant products included famotidine for an unknown indication. On Oct 9, 2021, at 1:33 pm, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Oct 9, 2021, patient experienced administered expired product (vaccine expired). On Oct 9, 2021, administered expired product (vaccine expired) resolved. The reporter did not provide any causality assessments. It was reported the patient has no known drug allergy. The patient has no chronic conditions. The patient had no adverse events. No treatment reported.
No AE; M-M-R II® (MEASLES/MUMPS/RUBELLA) Most Recent Temperature/ Temp Range ABOVE 47F (122.0F) for 13 hours 30 minutes and 0 seconds/ Most Recent Temperature/ VARIVAX® (VARICELLA VIRUS VAC, LIVE) Temp Range 122F/ (78F or warmer); Received transfer, who informed HCP stated she received late shipment on 8/7/2023 and should have been received on 8/6/2023 of VARIVAX and MMR II. Spoke with HCP who informed VARIVAX was given to 5patients. Additional AE on case 024518; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  Healthcare provider (HCP) stated she received late shipment on 07-AUG-2023 and should have been received on 06-AUG-2023 of varicella virus vaccine live (OKA/MERCK) (VARIVAX) (Product distribution issue). The vaccine had a temperature excursion due to late shipment. On 09-AUG-2023, the patient was vaccinated with an improperly storage varicella virus vaccine live (OKA/MERCK) (VARIVAX) subcutaneous injection, 0.5 milliliter/x1, valid lot #X010525, expiration date: 11-APR-2025, administered for prophylaxis (strength, and route of administration were not provided) (Product storage error). No additional adverse event was reported.
In January 2023, I had to go get my normal skin check. My doctor found that one of my moles had changed and did a biopsy. The result of the biopsy indicated that it was melanoma, which I had to get excised on 2/14/2023. I would like to add that I am currently pregnant, and my daughter is due 8/16/2023. At the time of this writing, I am doing well. I am just waiting for the site of the mole excision to heal.
I am the daughter of a late medical researcher Dr. so please listen to what I am saying - severe dizziness, nauseous, weakness, fatigue fever, chills, aches, bad taste, and very in mouth, and incredibly emotionally terrifying- those have subsided except at 7 weeks tomorrow - still dizzy, night sweats, over all weakness, and am scared. Am presently debilitated by this. Blood test came back with a higher ANA. Saw a rheumatologist and will follow up this Tuesday.  Periods have been thrown off as well. Got it two weeks ago and then again today. The worst is the dizziness and weakness. There must be more to treat people who are suffering like me.
The next day vaccine arm became sore and lasted 2 days. The second day after vaccine did not have energy. The day after that went away and I was fine. Rash appeared 12 days after vaccine, small red bumps, close to armpits and itchy.
Abnormal pain during shot that continued for several weeks. Pain worsened inflammation in bursa leading to medical attention
I can not pinpoint the date Trigger Finger on Left Hand first showed up. An internet search at that time did not get any "hits" in connection to Covid vaccine, however by 5/21/22 - when I scheduled a Dr. visit for 6/22/22 -  there were internet articles describing this issue as a side-effect of the Moderna booster. A cortisone shot in the palm, at the base of the ring finger provided immediate relief, with full recovery taking an additional month.
belly has been hurting; sour mouth; NAUSEA and felt like I would vomit; Stomach issues; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach issues), ABDOMINAL PAIN (belly has been hurting), DYSGEUSIA (sour mouth) and NAUSEA (NAUSEA and felt like I would vomit) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concomitant products included METOPROLOL SUCCINATE (TOPROL) for Hypertension.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach issues) and NAUSEA (NAUSEA and felt like I would vomit). On 01-Feb-2021, the patient experienced ABDOMINAL PAIN (belly has been hurting) and DYSGEUSIA (sour mouth). The patient was treated with SIMETICONE (GAS X) (oral) for Gastric irritation, at an unspecified dose and frequency and CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) (oral) for Gastric irritation, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Stomach issues), ABDOMINAL PAIN (belly has been hurting), DYSGEUSIA (sour mouth) and NAUSEA (NAUSEA and felt like I would vomit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Follow up was received. No new information was provided.
Patient DOB: 10/23/1995.  Received his single dose Janssen vaccine (LOT#: 205A21A EXP: 6/23/21) at 1054 on 5/22/21. Patient alerted EMT that he needed to lay down 1100. EMT walked patient to the cot. Patient laid down on the cot. EMT  took patients vital signs at 1105. BP: 160/118, pulse: 62, O2: 96%. Patient stated that he was feeling anxious. Patient was asked to stay an extra 30 minutes for observation. Patient was given a snack and water. EMT retook vital signs and reassessed patient at 1120. BP: 110/70, pulse: 72, O2: 97%. Patient stated that he was feeling better. EMT retook vital signs and reassessed patient at 1130. BP: 118/75, pulse: 63, O2: 97%. Patient stated he was feeling better. Patient completed observation time. Patient was educated on worsening signs and symptoms of vaccine and when to call EMS or seek emergency/ urgent care. Patient verbalized understanding of education. Patient completed his observation time. Patient walked out of vaccination site unassisted and with a steady gait at 1135.
Fever 103, arm swelling & hardness, pain, rash, flushing, chills, headache, sore throat, body ache, joint pain, redness,
Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Nausea-Mild, Systemic: Shakiness-Mild, Systemic: Visual Changes/Disturbances-Mild, Systemic: Weakness-Mild, Additional Details: made grunting sounds before passing out
Moderna CoVID -19Vaccine EUA. (Thursday) A red flushing on my neck and upper chest appeared on Saturday.   It did not itch or tingle and I felt fine.   On Sunday it tingled and was still  red but less than the day before.  Monday morning there was barely any evidence of it left.
Blood pumped in breast milk after 1st dose; Blood pumped in breast milk after 1st dose; Blood pumped in breast milk after 1st dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 37 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious), BREAST MILK DISCOLOURATION (non-serious), outcome "unknown" and all described as "Blood pumped in breast milk after 1st dose". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Day of the vaccine, approx. 5h later: Could not breathe. Feeling of not getting enough oxygen. Could not coordinate breathing and swallowing.  Reported to emergency room and received prednisone and Brenady orally. Went home. Breathing problems persisted for another 7 days. On December 8, 2021 (12 days post 3rd Moderna booster) I developed severe whole body urticaria.  Alongside the urticaria, shortness of breath was developed on Dec. 8. 21 which resulted in an emergency room visit where prednisone and an anti-histamine were administered I.V. Symptoms went away for about 24h after this treatment but the urticaria came back 24h later. The urticaria has become chronic since and is still ongoing to this date. No other sources for the urticaria were found. A dermatologist was consulted and an oral prednisone and Zyrtec treatment regimen was started on December 10, 2021.  Prednisone was started at 75mg, then reduced every 3 days and stopped January 6, 22. To this date only 10mg Zyrtec is taking every evening. Urticaria has become better but still appears every evening with more or less itchiness.
Swollen lymph node (right arm pit), violent chills, wave of cold spots at top of shoulders to base of neck and back of skull.